Clinical Trial: A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540754) titled 'A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function' on April 13.

Brief Summary: This is a Phase I clinical study to compare the pharmacokinetics (PK) of HRS9531 Injection in participants with mild/moderate hepatic impairment and participants with normal hepatic function, and to evaluate the safety of HRS9531 Injection in these participants.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus Weight Loss

Intervention: DRUG: HRS9531 Injection

HRS9531 injection, specified dose on the specified day.

Recruitment Status: NO...